Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy, Partial Seizures”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00351611
What this trial is testing

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 187
Large-scale testing (Phase 3)Study completedNCT00530855
What this trial is testing

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 322
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Not applicableStudy completedNCT02736162
What this trial is testing

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Who this might be right for
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 61
Large-scale testing (Phase 3)Study completedNCT00113165
What this trial is testing

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
EpilepsyEpilepsy, Partial
GlaxoSmithKline 244
Not applicableStudy completedNCT00922987
What this trial is testing

Clinical Study With Lyrica In Patients Suffering From Epilepsy

Who this might be right for
NeuralgiaEpilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 286
Testing effectiveness (Phase 2)Study completedNCT00416195
What this trial is testing

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT01496612
What this trial is testing

Buspirone Therapy for Localized Epilepsy

Who this might be right for
Anxiety DisorderSeizuresEpilepsy+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 9
Not applicableUnknownNCT04737837
What this trial is testing

A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Who this might be right for
EpilepsyFocal-Onset Seizure
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 200
Early research (Phase 1)Active Not RecruitingNCT06899230
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Who this might be right for
Drug Resistant EpilepsyFocal Seizure
iQure Australia Pty Ltd 72
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Large-scale testing (Phase 3)Enrolling By InvitationNCT05718817
What this trial is testing

An Open-label Study of XEN1101 in Epilepsy

Who this might be right for
Focal EpilepsyTonic-Clonic Seizures
Xenon Pharmaceuticals Inc. 880
Not applicableStudy completedNCT01457989
What this trial is testing

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline 1
Testing effectiveness (Phase 2)Study completedNCT01527513
What this trial is testing

Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 123
Not applicableUnknownNCT05635396
What this trial is testing

Seizures Detection in Real Life Setting

Who this might be right for
Epilepsy; SeizureFocal Epilepsy
Reliev Technologies 12
Large-scale testing (Phase 3)Study completedNCT00310375
What this trial is testing

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

Who this might be right for
Epilepsy
GlaxoSmithKline 181
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Not applicableStudy completedNCT01098162
What this trial is testing

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Who this might be right for
Epilepsies, Partial
UCB Pharma GmbH 576
Testing effectiveness (Phase 2)Ended earlyNCT04686786
What this trial is testing

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 105
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation